Patrick Grierson

1.3k total citations
38 papers, 514 citations indexed

About

Patrick Grierson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Grierson has authored 38 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Grierson's work include Pancreatic and Hepatic Oncology Research (16 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Patrick Grierson is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Patrick Grierson collaborates with scholars based in United States, China and United Kingdom. Patrick Grierson's co-authors include Kian‐Huat Lim, Joanna Groden, Samir Acharya, Manik Amin, Marianna B. Ruzinova, Andrea Wang‐Gillam, Daoxiang Zhang, George Ansstas, Sonika Dahiya and Tanner M. Johanns and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Patrick Grierson

33 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Grierson United States 14 271 206 119 85 59 38 514
Paula Kroon Netherlands 6 271 1.0× 283 1.4× 135 1.1× 125 1.5× 94 1.6× 10 539
Amar Desai United States 11 386 1.4× 185 0.9× 76 0.6× 157 1.8× 45 0.8× 23 599
Patrick M. Brauer United States 15 424 1.6× 246 1.2× 106 0.9× 42 0.5× 65 1.1× 23 606
Ki-Chun Yoo South Korea 14 291 1.1× 199 1.0× 61 0.5× 153 1.8× 61 1.0× 20 536
Agnete S. T. Engelsen Norway 13 252 0.9× 212 1.0× 203 1.7× 193 2.3× 44 0.7× 27 600
Peihong Ma United States 7 240 0.9× 128 0.6× 198 1.7× 130 1.5× 94 1.6× 8 487
Pavlina Chuntova United States 10 177 0.7× 187 0.9× 128 1.1× 83 1.0× 48 0.8× 15 415
S Hoffarth Germany 11 306 1.1× 224 1.1× 69 0.6× 109 1.3× 50 0.8× 12 565
Xiaohua Jie China 12 300 1.1× 168 0.8× 128 1.1× 110 1.3× 43 0.7× 17 474
Min Hwa Shin United States 12 193 0.7× 271 1.3× 240 2.0× 96 1.1× 29 0.5× 19 550

Countries citing papers authored by Patrick Grierson

Since Specialization
Citations

This map shows the geographic impact of Patrick Grierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Grierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Grierson more than expected).

Fields of papers citing papers by Patrick Grierson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Grierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Grierson. The network helps show where Patrick Grierson may publish in the future.

Co-authorship network of co-authors of Patrick Grierson

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Grierson. A scholar is included among the top collaborators of Patrick Grierson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Grierson. Patrick Grierson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grierson, Patrick, Rama Suresh, Andrea Wang‐Gillam, et al.. (2025). Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer. Clinical Cancer Research. 31(17). 3644–3651.
2.
3.
4.
Bansod, Sapana, Peng Liu, Lin Li, et al.. (2024). The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS. Cell Reports. 43(9). 114667–114667. 1 indexed citations
5.
Grierson, Patrick, Rama Suresh, Benjamin Tan, et al.. (2023). A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy. Clinical Cancer Research. 29(23). 4733–4739. 7 indexed citations
6.
Grierson, Patrick, Rama Suresh, Benjamin Tan, et al.. (2023). A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.. Journal of Clinical Oncology. 41(16_suppl). e16263–e16263. 1 indexed citations
7.
Grierson, Patrick, Benjamin Tan, Katrina S. Pedersen, et al.. (2022). Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma. The Oncologist. 28(2). e115–e123. 24 indexed citations
8.
Zhang, Daoxiang, Varintra E. Lander, Xiuting Liu, et al.. (2022). IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 162(7). 2047–2062. 33 indexed citations
9.
Grierson, Patrick, Iftikhar Ali Khawar, Daoxiang Zhang, et al.. (2021). The MK2/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress.. PubMed. 13(622). eabb5445–eabb5445. 13 indexed citations
10.
11.
Grierson, Patrick, et al.. (2021). Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects. World Journal of Gastroenterology. 27(18). 2105–2121. 31 indexed citations
12.
Pedersen, Katrina S., Patrick Grierson, Joel Picus, et al.. (2021). Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study. Investigational New Drugs. 39(5). 1298–1305. 25 indexed citations
13.
Khurana, Namrata, Daoxiang Zhang, Lin Li, et al.. (2020). TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations. Journal of Clinical Investigation. 130(9). 4771–4790. 24 indexed citations
14.
Sanjeevaiah, Aravind, Rama Suresh, Rutika Mehta, et al.. (2020). P-131 Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial. Annals of Oncology. 31. S132–S132. 1 indexed citations
15.
Grierson, Patrick, Rama Suresh, Kian‐Huat Lim, et al.. (2020). Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 11(1). 61–67. 5 indexed citations
16.
Li, Qiong, Yali Chen, Daoxiang Zhang, et al.. (2019). IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer. JCI Insight. 4(19). 31 indexed citations
17.
Jiang, Hongmei, Ming Xu, Lin Li, et al.. (2018). Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Molecular Cancer Therapeutics. 17(10). 2144–2155. 32 indexed citations
18.
19.
Grierson, Patrick, Kian‐Huat Lim, & Manik Amin. (2017). Immunotherapy in gastrointestinal cancers. Journal of Gastrointestinal Oncology. 8(3). 474–484. 37 indexed citations
20.
Bhattacharyya, Saumitri, et al.. (2011). Chromosome Breakage Is Regulated by the Interaction of the BLM Helicase and Topoisomerase IIα. Cancer Research. 71(2). 561–571. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Kroon Breakdown of academic impact, for papers by Amar Desai Breakdown of academic impact, for papers by Patrick M. Brauer Breakdown of academic impact, for papers by Ki-Chun Yoo Breakdown of academic impact, for papers by Agnete S. T. Engelsen Breakdown of academic impact, for papers by Peihong Ma Breakdown of academic impact, for papers by Pavlina Chuntova Breakdown of academic impact, for papers by S Hoffarth Breakdown of academic impact, for papers by Xiaohua Jie Breakdown of academic impact, for papers by Min Hwa Shin
Rankless by CCL
2026